Ionis Pharmaceuticals, Inc.’s Post

View organization page for Ionis Pharmaceuticals, Inc., graphic

68,837 followers

We’re proud to share The New England Journal of Medicine, part of NEJM Group, today published the positive Phase 3 OASIS-HAE results for our investigational medicine for the treatment of hereditary angioedema (#HAE), which were simultaneously presented in a late-breaking session at #EAACIcongress.     Read the full article to learn more about these exciting results: https://lnkd.in/e9Sb76UZ

  • No alternative text description for this image

This is very exciting, bravo Ionis Pharmaceuticals, Inc. !

Like
Reply

To view or add a comment, sign in

Explore topics